Singapore Diagnostics (SGD), a leading medical laboratory in the Philippines, has been honored with the prestigious title of “Diagnostics Provider of the Year” at the Healthcare Asia Awards. This recognition highlights SGD’s outstanding contributions and innovative initiatives in the healthcare industry.
Under the theme of “Recognizing Trailblazing Initiatives in the Healthcare Sector” this year’s Healthcare Asia Awards acknowledges healthcare institutions across Asia that have risen to the challenges posed by the post-pandemic landscape. The awards program evaluated the performances of healthcare institutions over the past 24 months, considering their innovative approaches and reinvented initiatives aimed at improving patient care and ensuring the well-being of healthcare workers. Institutions were required to identify the challenges they faced, detail the solutions they implemented, and highlight the unique and innovative strategies employed to overcome these obstacles. SGD received accolades from the judging panel for successfully navigating the industry’s challenges related to quality, accessibility, and skills.
This recognition serves as an encouragement for SGD to further its efforts in enhancing accessibility and affordability, raising the bar for quality, and investing in the training and development of Filipino laboratory scientists. SGD remains committed to advancing healthcare services in the Philippines and continuously pushing the boundaries of excellence in diagnostics.
SGD Earns Healthcare Asia Awards Recognition Alongside Other Asian Awardees
Singapore Diagnostics (SGD), a subsidiary of Pathology Asia (PAH), has been honored with the “Diagnostics Provider of the Year” award at the Healthcare Asia Awards. This prestigious recognition acknowledges SGD’s exceptional contributions and innovative initiatives in the healthcare industry. SGD was among the esteemed awardees from various Asian countries recognized in 27 categories.
In addition to this achievement, SGD has secured a spot on this year’s list of Philippine Growth Champions by Statista, a renowned international market research firm. This exclusive list features the top 25 businesses that have made substantial contributions to the rapid growth and business environment in the Philippines.
Last year, SGD received re-accreditation from the esteemed College of American Pathologists, further solidifying its commitment to excellence. SGD has been CAP Accredited since 2019, a distinction shared by only a few international laboratories.
Since its establishment in the Philippines in 2013, SGD has been serving over 600 hospitals, clinics, laboratories, and healthcare institutions across the country. Processing laboratory requirements for up to 50,000 patients each month and conducting approximately 3.5 million laboratory examinations annually, SGD plays a vital role in the healthcare landscape.
Moreover, SGD serves as a training ground for Filipino medical technologists and clinicians who have gone on to excel in leading hospitals and healthcare institutions worldwide. Through its comprehensive training programs, SGD contributes to the development of highly skilled professionals in the medical field.
These accolades and achievements highlight SGD’s commitment to delivering top-quality diagnostic services, fostering growth in the healthcare industry, and contributing to the advancement of healthcare professionals in the Philippines and beyond.
